Found: 20
Select item for more details and to access through your institution.
Editorial Board.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. A4, doi. 10.1016/S2152-2650(21)00140-3
- Publication type:
- Article
Treatment of Acute Leukemia During COVID-19: Focused Review of Evidence.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 289, doi. 10.1016/j.clml.2021.01.004
- By:
- Publication type:
- Article
Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 295, doi. 10.1016/j.clml.2020.12.018
- By:
- Publication type:
- Article
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 309, doi. 10.1016/j.clml.2020.12.012
- By:
- Publication type:
- Article
Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 318, doi. 10.1016/j.clml.2020.12.024
- By:
- Publication type:
- Article
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 328, doi. 10.1016/j.clml.2021.01.013
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 338, doi. 10.1016/j.clml.2020.12.025
- By:
- Publication type:
- Article
Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival Endpoint.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 345, doi. 10.1016/j.clml.2020.12.021
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
- By:
- Publication type:
- Article
Treatment-Induced Aggravation of Vasculitis in Hairy-Cell Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e429, doi. 10.1016/j.clml.2020.12.019
- By:
- Publication type:
- Article
Retrospective Analysis of the Impact of Adverse Event–Triggered Idelalisib Interruption and Dose Reduction on Clinical Outcomes in Patients With Relapsed/Refractory B-Cell Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e432, doi. 10.1016/j.clml.2020.12.016
- By:
- Publication type:
- Article
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e449, doi. 10.1016/j.clml.2020.12.023
- By:
- Publication type:
- Article
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e456, doi. 10.1016/j.clml.2020.12.022
- By:
- Publication type:
- Article
Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e460, doi. 10.1016/j.clml.2021.01.001
- By:
- Publication type:
- Article
Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e464, doi. 10.1016/j.clml.2020.12.015
- By:
- Publication type:
- Article
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e470, doi. 10.1016/j.clml.2020.12.026
- By:
- Publication type:
- Article
Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e477, doi. 10.1016/j.clml.2020.10.014
- By:
- Publication type:
- Article
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e483, doi. 10.1016/j.clml.2021.01.003
- By:
- Publication type:
- Article
Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e488, doi. 10.1016/j.clml.2021.01.023
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. A6,A10, doi. 10.1016/S2152-2650(21)00141-5
- Publication type:
- Article